Teicoplanin inhibits the release of the viral genome and the viral replication cycle by cleaving the spike protein at low pH with cathepsin L, which enters the cell and targets the S protein in case of COVID-19, at the late endosomes during the early stages of viral replication [186]. This evidence concerns the gene PROS1 and COVID-19.